Business
Paradigm (ASX:PAR) share price shoots 30% higher on FDA update
Image source: Getty Images
The Paradigm Biopharmaceuticals Ltd (ASX: PAR) share price has returned from its trading halt and is charging higher on Wednesday.
At the time of writing, the biopharmaceutical company’s shares are up 30% to $2.69.
Why is the Paradigm share price charging higher?
…
Continue Reading
-
General20 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News24 hours agoSouth-west Queensland highway closed after truck carrying oxygen cylinders catches fire
-
General22 hours agoBack-to-back rate cuts tipped when Reserve Bank meets
-
Noosa News22 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland